Osemitamab is a recombinant IgG1 monoclonal antibody specifically designed to target human claudin-18.2. This antibody is comprised of a human-Mus musculus monoclonal TST001 gamma 1-chain linked via disulfide bonds to a human-Mus musculus monoclonal TST001 kappa-chain, forming a dimeric structure. When used in conjunction with Capecitabine and Oxaliplatin, Osemitamab serves as a potent investigational tool for the study of gastric (G) and gastroesophageal junction (GEJ) cancers. This specificity and application make it a valuable asset for targeted cancer therapy research.
Osemitamab is a recombinant IgG1 monoclonal antibody specifically designed to target human claudin-18.2. This antibody is comprised of a human-Mus musculus monoclonal TST001 gamma 1-chain linked via disulfide bonds to a human-Mus musculus monoclonal TST001 kappa-chain, forming a dimeric structure. When used in conjunction with Capecitabine and Oxaliplatin, Osemitamab serves as a potent investigational tool for the study of gastric (G) and gastroesophageal junction (GEJ) cancers. This specificity and application make it a valuable asset for targeted cancer therapy research.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
